idelalisib and HIV-Infections

idelalisib has been researched along with HIV-Infections* in 1 studies

Other Studies

1 other study(ies) available for idelalisib and HIV-Infections

Article	Year
Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation. Annals of hematology, 2021, Volume: 100, Issue:1 Topics: Aged; Antineoplastic Agents; Burkitt Lymphoma; Class I Phosphatidylinositol 3-Kinases; Comorbidity; High-Throughput Screening Assays; HIV Infections; Humans; Magnetic Resonance Imaging; Male; Mutation; Purines; Quinazolinones; Recurrence; Tumor Suppressor Protein p53	2021

Article

Year

Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation.

Annals of hematology, 2021, Volume: 100, Issue:1

Topics: Aged; Antineoplastic Agents; Burkitt Lymphoma; Class I Phosphatidylinositol 3-Kinases; Comorbidity; High-Throughput Screening Assays; HIV Infections; Humans; Magnetic Resonance Imaging; Male; Mutation; Purines; Quinazolinones; Recurrence; Tumor Suppressor Protein p53

2021